Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. - Wikidata - awgldk - TriplyDB

Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

http://www.wikidata.org/entity/Q39677752

about

Curcumin AntiCancer Studies in Pancreatic Cancer Natural product-based nanomedicine: recent advances and issues Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics Therapeutic Potential of Curcumin for the Treatment of Brain Tumors Convergence of nanotechnology and cancer prevention: are we there yet?Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells.Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.Curcumin loaded NIPAAM/VP/PEG-A nanoparticles: physicochemical and chemopreventive properties.The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease.Cancer stem cells: potential target for bioactive food components A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.Therapeutic Applications of Curcumin Nanoformulations A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy.Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk popul Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model.Curcumin nanomedicine: a road to cancer therapeutics A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery.Integrative nanomedicine: treating cancer with nanoscale natural products.Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment Therapeutic potential of curcumin in gastrointestinal diseases.Curcumin nanoformulations: a future nanomedicine for cancer.Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.The role of cancer stem cells in the anti-carcinogenicity of curcumin.Encapsulation of natural polyphenolic compounds; a review.Recent advances in curcumin nanoformulation for cancer therapy.Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.Curcumin Nanotechnologies and Its Anticancer Activity.A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways.

P2860

Q26738714-80ADC795-2871-4C7E-86CD-CEA5F3FFD1AE Q26785633-5D252329-405F-4183-8AD0-F9F624495314 Q27026623-48C85D41-7A63-4849-A6E6-3CF8829133AF Q28071572-C0D1F68A-1427-439F-BC48-0D98226C0B5D Q28386699-69FED0F1-25B1-41AE-855A-8E2238500464 Q28476783-403722D4-7095-40F2-9F9B-259E94C89ADC Q30978432-39BC1703-1CB2-407C-BBED-5993DD6446B4 Q33831661-ECEF6BF0-7E85-4AA5-98EE-C59FF4351866 Q34120334-CE37BB0A-7F75-4FBD-AD28-C584FB8103D9 Q34600157-3BB88A61-5398-4CB3-8811-A00137BE6BAB Q34658997-F8803D7D-BC49-4660-882E-658EE9534270 Q34690409-942AA354-EE0F-4FD4-8D56-623357586115 Q34928908-DBC812F8-F6FF-48A8-A75B-94FAB770A39E Q35225869-F992CF4D-7A96-407C-A143-3D3B38BE33FC Q35576287-474730EE-589D-4B91-916A-9BE5ADE547F0 Q35828603-89050AD0-3222-478C-B867-8A2DBC690188 Q35898800-F592EE10-8594-4675-A71C-E3B536396306 Q35939307-76C35A91-7C17-4C9A-BBD1-69C5902E78B4 Q36232513-51628508-0F84-48E3-855B-818389EF145E Q36234061-722E4DE9-7B2E-4C83-BC74-9997E1A2DEED Q36647007-DE96B47E-AB86-4FA9-9823-A7F66F65DBCB Q36756833-7794452F-4606-4631-A1A3-B09C26D6B452 Q36807261-91E8A584-D828-4C4C-9FBD-C5A330BE2BA7 Q36851289-3AB437A3-8AD9-4BEE-BAEE-836109561642 Q36931429-23864AC9-99F7-45C6-A973-25C0FA314E0E Q37248684-14ED06AB-3199-4D12-B483-7466A3854367 Q37578847-31F7A545-A016-41D4-9FE6-C963451DBCF5 Q37662418-DB73F39B-41D6-4D31-8B98-82095FEA1493 Q37878888-8853FC4E-E719-4FA6-8C57-EB971A39AD57 Q37940793-438DD997-E849-4C32-ACF0-C51146E9F790 Q37994505-B82A9620-AC44-4F75-AFB6-8FCFBF8FC5F8 Q38042744-1398C2A3-463E-40EC-A26A-CC38920DA876 Q38125426-5A20F238-E8A7-49A5-9FD8-6C8C7E30FCC9 Q38168994-A5D50B5D-E2AD-4A71-A85A-4F1F1B29AF6B Q38214381-9777269E-660D-422F-BF76-2CE5D6D1511E Q38525432-7EDA3B5A-1EEB-41AF-9366-D4C4DCB2E199 Q38746695-89712D49-7380-4303-9A0C-1764C8D14693 Q38758760-B8D4F3E6-16AE-427D-B99A-F64CC821897B Q38768150-559AFD16-F7F8-4EF8-86EB-27D6AF9E0135 Q38832201-26B5AA4A-69B6-4AAD-9CFC-6EF9D0DD5FAD

P2860

Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

http://www.wikidata.org/entity/Q39677752

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Systemic administration of pol ...... l models of pancreatic cancer.

@en

Systemic administration of polymeric nanoparticle-encapsulated curcumin

@nl

type

label

Systemic administration of pol ...... l models of pancreatic cancer.

@en

Systemic administration of polymeric nanoparticle-encapsulated curcumin

@nl

prefLabel

Systemic administration of pol ...... l models of pancreatic cancer.

@en

Systemic administration of polymeric nanoparticle-encapsulated curcumin

@nl

P1433

Q39677752-19B8FEF7-FADA-42DD-98AD-E25410DFB69B

P1476

Q39677752-717846E9-EBBF-422D-93E5-69B65591349A

P2093

Q39677752-03B05ADC-6218-4AE3-86B0-C9C33D2E58AC

Q39677752-0951B960-A6AA-4E99-AB12-75ABCFF79133

Q39677752-27C6F41D-7AC5-4ACD-80A5-DB0AF107949C

Q39677752-2FFB7BEE-4978-49A1-8706-74C09A9A8F26

Q39677752-4D7451FE-0A4C-4711-8DD0-D92A48ED7452

Q39677752-5F5F85EB-604D-4120-9844-E9E108E67D2D

Q39677752-69AB4365-6F18-4ADB-BF66-B4680674EE6E

Q39677752-7758E8DD-545C-4D48-A3AD-6194F1B63D33

Q39677752-AAB3BDC9-6826-4833-AE1C-A356E935974D

Q39677752-D09A56E1-487F-4785-A513-941AD2222274

P2860

Q39677752-023A449A-1CD0-4B4E-B87B-D9E3FCE334F8

Q39677752-02FAFB67-4B4C-4C4C-9B6F-692615254199

Q39677752-038D3840-9DB5-4DEB-8A31-33118DAC42A5

Q39677752-06DE541B-0F45-41B9-8829-D18C64B7E3E8

Q39677752-0A9ECB46-70D8-4A2A-8731-4B7DC438ADCA

Q39677752-115B0B71-7FDB-4DDF-A665-A998DDD7AA43

Q39677752-12702966-F7C4-4C24-B0D3-78E2510EB4F0

Q39677752-177960AE-7D79-4F5C-B0D9-7FB9C889D53B

Q39677752-1EB8F185-D1B3-4167-B2BE-00E31D87E0C7

Q39677752-30324EC7-9E2B-443A-BDB6-EF35EDF1E9F1

P304

Q39677752-1D44B427-F3F8-4C88-B5C4-29159D0C00AD

P31

Q39677752-4BDB6CE5-CDF5-4AE7-A292-F134225477EF

P356

Q39677752-C1B5E84D-484A-45BE-9E49-AA1D77828485

P433

Q39677752-F532DE6A-BA45-410B-91CC-6CA107948FF4

P478

Q39677752-8EFC77B2-D2E1-4970-87E8-92CBCDCFD680

P50

Q39677752-A7688D88-535D-468C-A818-FCA95BED7BC4

Q39677752-FD319C01-07EF-492E-83DF-8295EC80C12C

P577

Q39677752-A36E6FA1-031F-403C-A56E-4FB72C7A2608

P698

Q39677752-2DE0DB95-A17A-40FF-A118-D9C11D2C4E56

P921

Q39677752-029bec4d-e2b5-4808-8114-c926ad4f424f

Q39677752-9C890F7B-45E7-4114-99C5-451E46BE7284

P932

Q39677752-ABC32376-16F5-4B38-B764-340DB4F24AB3

P356

1535-7163.MCT-10-0172

P1433

Molecular Cancer Therapeutics

P1476

Systemic administration of pol ...... al models of pancreatic cancer

@en

P2093

Amarnath Maitra

http://www.w3.org/2001/XMLSchema#string

Anirban Maitra

http://www.w3.org/2001/XMLSchema#string

Collins Karikari

http://www.w3.org/2001/XMLSchema#string

Dipankar Pramanik

http://www.w3.org/2001/XMLSchema#string

Georg Feldmann

http://www.w3.org/2001/XMLSchema#string

Masamichi Mizuma

http://www.w3.org/2001/XMLSchema#string

Michael G Goggins

http://www.w3.org/2001/XMLSchema#string

Michelle A Rudek

http://www.w3.org/2001/XMLSchema#string

Niki A Ottenhof

http://www.w3.org/2001/XMLSchema#string

Rajani Ravi

http://www.w3.org/2001/XMLSchema#string

P2860

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Bioavailability of curcumin: problems and promises

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

NF-kappaB in cancer: from innocent bystander to major culprit

Pancreatic cancer.

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin.

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.

Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

Epidemiology of digestive tract cancers in India. V. Large and small bowel.

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

P304

2255-2264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-10-0172

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Rajni B. Sharma

P577

2010-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20647339

http://www.w3.org/2001/XMLSchema#string

P921

P932

2942082

http://www.w3.org/2001/XMLSchema#string